Skip to main content
Scheduling

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More

Clay T. Cohen, MD

Location

Texas Medical Center

Specialty
Cancer and Hematology
Phone: 832-822-4242
Fax: 832-825-1453
Office Phone
832-822-1526
Email

ctcohen@texaschildrens.org

Address

6701 Fannin St., Ste. 1580.34
Houston, TX 77030

Clay T. Cohen, MD

Associate Chief, Hematology
Director, Hemophilia Treatment Center
Associate Director, Young Women's Bleeding Disorders Clinic
Assistant Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine

Education

School Education Degree Year
Baylor College of Medicine Fellowship Pediatric Hematology/Oncology 2018
Baylor College of Medicine Postgraduate Training Clinical Scientist Training Program, Fundamentals of Clinical Investigation 2016
University of Alabama School of Medicine - Birmingham Residency Pediatrics 2015
University of Alabama at Birmingham Internship Pediatrics 2012
University of Texas Medical School at Houston Medical School Doctor of Medicine 2011
Furman University Bachelors Bachelor of Science, Biology 2007

About

Dr. Clay Cohen is a pediatric hematologist with clinical expertise in children and adolescents with bleeding and clotting disorders. Dr. Cohen is the Director of the Hemophilia Treatment Center at Texas Children’s Hospital where he provides care for patients with hemophilia, Von Willebrand disease, platelet function disorders, and other rare bleeding disorders. The Texas Children’s Hemophilia Treatment Center provides comprehensive care to children with bleeding disorders, including evaluation and treatment by hematology-focused physical therapists, medical geneticists, social workers, nursing coordinators, and nutritionists to provide optimal care.  

Dr. Cohen is also Associate Director of the Texas Children’s Young Women’s Bleeding Disorder Clinic, a combined hematology-gynecology clinic, where he evaluates patients with heavy menstrual bleeding for an underlying bleeding disorder and offers treatment for the often-resulting iron deficiency. As young women with Von Willebrand Disease often present with heavy menstrual bleeding, he can diagnose, counsel, and treat patients and their families in this combined clinic.   

Dr. Cohen is a member of the Texas Children’s hemostasis and thrombosis clinical program where he offers consultation and assistance to children with serious bleeding and clotting disorders and complications on an inpatient and outpatient setting. He also enjoys clinical education and is on the American Academy of Pediatrics (AAP) Hematology/Oncology PREP Editorial Board.

In addition to his clinical work, Dr. Cohen also performs basic science research, investigating the role of human endothelial cells in coagulation. To date he has discovered that human endothelial cells produce the active coagulation proteins necessary to activate the critical coagulation proteins, factor X and thrombin. 

Dr. Cohen is a graduate of the University of Texas Medical School at Houston. He completed his residency in pediatrics at University of Alabama School of Medicine - Birmingham where he was appointed as Chief Pediatric Resident. He completed his fellowship training in pediatric hematology/oncology at Baylor College of Medicine. 

He is board certified by the American Board of Pediatrics in both pediatrics and pediatric hematology/oncology.

Organizations

Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society of Hematology (ASH) Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member
Foundation for Women & Girls with Bleeding Disorders (FWGBD) Member
Hemostasis and Thrombosis Research Society (HTRS) Member
International Society of Thrombosis and Haemostasis (ISTH) Done

Research Statement

Dr. Clay Cohen performs basic laboratory research, evaluating the role of endothelial cells and the vascular wall in coagulation. He is a member of the Hemostasis and Thrombosis (HAT) research program.

Awards & Honors

2022     Fellows' Excellence in Education Award, Texas Children's Cancer & Hematology Center
2021     Scientific Symposium Abstract Award, Hemostasis and Thrombosis Research Society
2020     Mentored Research Award, Hemostasis and Thrombosis Research Society
2018     Fellowship Project Award, Bayer Hemophilia Awards Program
2018     Young Investigator Travel Award, Thrombosis and Hemostasis Societies of North America 
2016     Tumor Board Award, Department of Pediatric Medicine, Hematology-Oncology, Baylor College of Medicine
2014     Best Quality Improvement Project for graduating Pediatric Residents, University of Alabama at Birmingham
2014     Chief Resident, Department of Pediatrics, University of Alabama at Birmingham
2011     Joe LaRussa Intern of the Year Award, Department of Pediatrics, University of Alabama at Birmingham

Board Certification

American Board of Pediatrics, American Board of Pediatrics - Pediatric Hematology/Oncology

Language

English



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.